OncoSil Medical LtdASX: OSL

Peer-Reviewed Study Reports 100% Disease Control

· Issued by OncoSil Medical Ltd via ASX

Filed with ASX ·

ASX Announcement 27 October 2026 OncoSil™ Study Reports 100% Local Disease Control and Promising Surgical Outcomes in Locally Advanced Pancreatic Cancer Key highlights • Peer-reviewed clinical study published in the international oncology journal Cancers, reporting early outcomes in 17 patients...

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases